Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions

Transplantation

Volumn 61, Issue 2, 1996, Pages 292-299

  Mckisic, Maureen D ^a   Paturzo, Frank X ^a   Smith, Abigail L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; EFFECTOR CELL; GRAFT REJECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; SARCOMA, EXPERIMENTAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030021550     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601270-00022     Document Type: Article

References (39)

1. McKisic MD, Lancki DW, Otto G, et al. Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol 1993; 150: 419.
2. Smith AL, Jacoby RO, Johnson EA, Paturzo F, Bhatt PN. In vivo studies with an "orphan" parvovirus of mice. Lab Anim Sci 1993; 43: 175.
3. Jacoby RO, Johnson EA, Ball-Goodrich L, Smith AL, McKisic MD. Characterization of mouse parvovirus infection by in situ hybridization. J Virol 1995; 69: 3915.
4. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 1987; 33: 91.
5. Pattison JR. Parvoviruses medical and biological aspects. In: Fields BN, Knipe DM, eds. Fields virology, Vol 2. New York: Raven, 1990: 1765.
6. Tattersall P, Cotmore SF. The rodent parvoviruses. In: Bhatt PN, Jacoby RO, Morse III HC, New AE, eds. Viral and mycoplasmal infections of laboratory rodents. Effects on biomedical research. Orlando: Academic Press, 1986: 305.
7. Berns KI. Parvovirus replication. Microbiol Rev 1990; 54: 316.
8. Bonnard GD, Manders EK, Campbell DA Jr, Herberman RB, Collins MJ Jr. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma: evidence for minute virus of mice causing the inhibition. J Exp Med 1976; 143: 187.
9. Engers HD, Louis JA, Zubler RH, Hirt B. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J Immunol 1981; 127: 2280.
10. Crawford LV. A minute virus of mice. Virol 1966; 29: 605.
11. Guetta E, Graziani Y, Tal J. Suppression of Ehrlich ascites tumors in mice by minute virus of mice. J Natl Cancer Inst 1986; 76: 1177.
12. Kimsey PB, Engers HD, Hirt B, Jongeneel CV. Pathogenicity of fibroblast- and lymphocyte-specific variants of minute virus of mice. J Virol 1986; 59: 8.
13. Ball-Goodrich LJ, Johnson EA. Molecular characterization of a newly recognized mouse parvovirus. J Virol 1994; 68: 6476.
14. Tattersall P, Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J Virol 1983; 46: 944.
15. Gardiner EM, Tattersall P. Mapping of the fibrotropic and lymphotropic host range determinants of the parvovirus minute virus of mice. J Virol 1988; 62: 2605.
16. Smith AL. Response of weanling random-bred mice to inoculation of minute virus of mice. Lab Anim Sci 1983; 33: 37.
17. Glasebrook AL, Sarmiento M, Loken MR, et al. Murine T lymphocyte clones with distinct immunological functions. Immunol Rev 1981; 54: 225.
18. Glasebrook AL, Fitch FW. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med 1980; 151: 876.
19. Smith DM, Fitch FW. Cellular stimuli for rejection of Sarcoma I tumor allografts by BALB/c recipient mice. Cell Immunol 1989; 118: 358.
20. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc Natl Acad Sci USA 1982; 79: 3604.
21. Cerottini JC, Engers HD, MacDonald HR, Brunner KT. Generation of cytotoxic T lymphocytes in vitro: I. Response of normal and immune mouse spleen cells in mixed lymphocyte cultures. J Exp Med 1974; 140: 703.
22. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: A new fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077.
23. Fitch FW and Gajewski TF. Production of T cell clones. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current protocols in immunology. New York: Green and Wiley, 1991: 3.13.1.
24. Smith DM, Stuart FP, Wemhoff GA, Quintans J, Fitch FW. Cellular pathways for rejection of class-I-MHC-disparate skin and tumor allografts. Transplantation 1988; 45: 168.
25. Fikrig MK, Tattersall P. Latent parvoviral infection of continuous cell lines. Dev Biol Standard 1992; 76: 285.
26. Rommelaere J, Cornelis JJ. Antineoplastic activity of parvoviruses. J Virol Methods 1991; 33: 233.
27. Jacoby RO, Bhatt PN, Jonas AM. Viral diseases. In: Baker HJ, Lindsey JR, Weisbroth SH, eds. The laboratory rat. Vol 1. Biology and diseases. New York: Academic, 1979: 272.
28. Martz E, Howell DM. CTL: virus control cells first and cytolytic cells second? Immunol Today 1989; 10: 79.
29. Doherty PC, Allan W, Eichelberger M. Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 1992; 10: 123.
30. Jennings SR, Rice PL, Kloszewski ED, Anderson RW, Thompson DL, Tevethia SS. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol 1985; 56: 757.
31. Massa PT, Dorries R, ter Meulen V. Viral particles induce Ia antigen expression on astrocytes. Nature 1986; 320: 543.
32. Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PD, Poulter LW. Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection. J Med Virol 1988; 25: 483.
33. Suzumura A, Lavi E, Weiss SR, Silberberg DH. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 1986; 232: 991.
34. Oldstone MBA. Viral persistence. Cell 1989; 56: 517.
35. Stuart PM, Cassell GH, Woodward JG. Induction of class II MHC antigen expression in macrophages by Mycoplasma species. J Immunol 1989; 142: 3392.
36. Boshkov LK, Macen JL, McFadden G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol 1992; 148: 881.
37. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol 1994; 152: 2736.
38. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994; 76: 323.
39. Torok TJ. Parvovirus B19 and human disease. Adv Intern Med 1992; 37: 431.